Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer

Cynthia X. Ma, Suresh Nair, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, Alex A. Adjei

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint Dive into the research topics of 'Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences